Cagatay Culcuoglu, Co-Founder of Massive Bio, to Speak at ‘Innovation in Oncology’ Event
2023.12.05
Join us for a thought-provoking discussion on ‘Innovation in Oncology: From Molecular Diagnosis to New Therapies’ in the beautiful Principality of Asturias, Spain.
This engaging colloquium promises to delve deep into the nuances of the cancer patient’s journey. From initial diagnosis to cutting-edge therapies, the focus will firmly be on the transformative power of personalized medicine and precision oncology.
We’re thrilled to share that our co-founder, Cagatay Culcuoglu, will be gracing the panel! Drawing from his rich personal experiences and Massive Bio’s groundbreaking initiatives, Cagatay will shed light on the pivotal role of innovation in enhancing the cancer patient’s journey.
Come, be a part of this enlightening discussion, and engage with some of the brightest minds in the realm of oncology! Together, let’s envision and shape a future where every cancer patient benefits from the marvels of modern science and technology.
Recent In Massive Bio
Massive Bio’s Co-Founder Dr. Arturo Loaiza-Bonilla Participates in Europe’s Leading Health Tech Event
2023.12.05
Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally
2023.12.05
Massive Bio and Health in Code Collaborate to Enhance Personalized Oncology Treatment Through Advanced Genomic Testing
2023.12.05
Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023
2023.12.05
Cagatay Culcuoglu, Co-Founder of Massive Bio, to Speak at ‘Innovation in Oncology’ Event
2023.12.05